My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1364

    1.

    Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.

    Weigert G, Michels S, Sacu S, Varga A, Prager F, Geitzenauer W, Schmidt-Erfurth U.

    Br J Ophthalmol. 2008 Mar;92(3):356-60.PMID: 18303156 [PubMed - indexed for MEDLINE]Related articles

    2.

    Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

    Retina. 2007 Apr-May;27(4):432-8.PMID: 17420694 [PubMed - indexed for MEDLINE]Related articles

    3.

    Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.

    Ahmadieh H, Taei R, Soheilian M, Riazi-Esfahani M, Karkhaneh R, Lashay A, Azarmina M, Dehghan MH, Moradian S.

    BMC Ophthalmol. 2007 Jun 7;7:10.PMID: 17555600 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Triple therapy for neovascular age-related macular degeneration using single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone.

    Yip PP, Woo CF, Tang HH, Ho CK.

    Br J Ophthalmol. 2009 Jun;93(6):754-8. Epub 2009 Mar 8.PMID: 19273471 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    [Intravitreal bevacizumab versus verteporfin and intravitreal triamcinolone acetonide in patients with neovascular age-related macula degeneration]

    Hahn R, Sacu S, Michels S, Varga A, Weigert G, Geitzenauer W, Vécsei-Marlovits P, Schmidt-Erfurth U.

    Ophthalmologe. 2007 Jul;104(7):588-93. German. PMID: 17564719 [PubMed - indexed for MEDLINE]Related articles

    6.

    Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.

    Lazic R, Gabric N.

    Ophthalmology. 2007 Jun;114(6):1179-85.PMID: 17544776 [PubMed - indexed for MEDLINE]Related articles

    7.

    Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.

    Chaudhary V, Mao A, Hooper PL, Sheidow TG.

    Ophthalmology. 2007 Dec;114(12):2183-9.PMID: 18054638 [PubMed - indexed for MEDLINE]Related articles

    8.

    Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.

    Chan WM, Lai TY, Wong AL, Tong JP, Liu DT, Lam DS.

    Br J Ophthalmol. 2006 Mar;90(3):337-41.PMID: 16488958 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone.

    Arias L, Garcia-Arumi J, Ramon JM, Badia M, Rubio M, Pujol O.

    Graefes Arch Clin Exp Ophthalmol. 2008 Feb;246(2):245-54. Epub 2007 Aug 3.PMID: 17674020 [PubMed - indexed for MEDLINE]Related articles

    10.

    Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).

    Costa RA, Jorge R, Calucci D, Melo LA Jr, Cardillo JA, Scott IU.

    Graefes Arch Clin Exp Ophthalmol. 2007 Sep;245(9):1273-80. Epub 2007 Feb 28.PMID: 17333238 [PubMed - indexed for MEDLINE]Related articles

    11.

    Combined intravitreal bevacizumab and photodynamic therapy for neovascular age-related macular degeneration.

    Ladewig MS, Karl SE, Hamelmann V, Helb HM, Scholl HP, Holz FG, Eter N.

    Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):17-25. Epub 2007 Aug 15.PMID: 17701197 [PubMed - indexed for MEDLINE]Related articles

    12.

    Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.

    Kaiser PK; Registry of Visudyne AMD Therapy Writing Committee, Boyer DS, Garcia R, Hao Y, Hughes MS, Jabbour NM, Kaiser PK, Mieler W, Slakter JS, Samuel M, Tolentino MJ, Roth D, Sheidow T, Strong HA.

    Ophthalmology. 2009 Apr;116(4):747-55, 755.e1. Epub 2009 Feb 25.PMID: 19243834 [PubMed - indexed for MEDLINE]Related articles

    13.

    Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.

    Arias L, Garcia-Arumi J, Ramon JM, Badia M, Rubio M, Pujol O.

    Ophthalmology. 2006 Dec;113(12):2243-50. Epub 2006 Sep 25.PMID: 16996600 [PubMed - indexed for MEDLINE]Related articles

    14.

    Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

    Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ.

    Ophthalmology. 2006 Mar;113(3):363-372.e5. Epub 2006 Feb 3.PMID: 16458968 [PubMed - indexed for MEDLINE]Related articles

    15.

    Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

    Rich RM, Rosenfeld PJ, Puliafito CA, Dubovy SR, Davis JL, Flynn HW Jr, Gonzalez S, Feuer WJ, Lin RC, Lalwani GA, Nguyen JK, Kumar G.

    Retina. 2006 May-Jun;26(5):495-511.PMID: 16770255 [PubMed - indexed for MEDLINE]Related articles

    16.

    Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.

    Smith BT, Dhalla MS, Shah GK, Blinder KJ, Ryan EH Jr, Mittra RA.

    Retina. 2008 May;28(5):675-81.PMID: 18463509 [PubMed - indexed for MEDLINE]Related articles

    17.

    Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study.

    Moshfeghi AA, Rosenfeld PJ, Puliafito CA, Michels S, Marcus EN, Lenchus JD, Venkatraman AS.

    Ophthalmology. 2006 Nov;113(11):2002.e1-12. Epub 2006 Oct 5.PMID: 17027972 [PubMed - indexed for MEDLINE]Related articles

    18.

    Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.

    Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia MJ, Costa RA; Pan-American Collaborative Retina Study Group.

    Retina. 2008 Nov-Dec;28(10):1387-94.PMID: 18827735 [PubMed - indexed for MEDLINE]Related articles

    19.

    Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.

    Augustin AJ, Schmidt-Erfurth U.

    Ophthalmology. 2006 Jan;113(1):14-22. Epub 2005 Dec 19.PMID: 16360209 [PubMed - indexed for MEDLINE]Related articles

    20.

    Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage.

    Stifter E, Michels S, Prager F, Georgopoulos M, Polak K, Hirn C, Schmidt-Erfurth U.

    Am J Ophthalmol. 2007 Dec;144(6):886-892. Epub 2007 Oct 4.PMID: 17916314 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity